ACADIA Pharmaceuticals, Inc. (ACAD)
21.51
+0.90
(+4.37%)
USD |
NASDAQ |
Mar 16, 13:26
ACADIA Pharmaceuticals EPS Diluted (Quarterly) : 1.596 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| Marker Therapeutics, Inc. | -0.1193 |
| Agilent Technologies, Inc. | 1.074 |
| Axsome Therapeutics, Inc. | -0.5641 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 273.57M |
| Revenue (Quarterly) | 283.99M |
| Total Expenses (Quarterly) | 10.42M |
| Enterprise Value | 2.746B |
| Gross Profit Margin (Quarterly) | 90.77% |
| Profit Margin (Quarterly) | 96.33% |
| Earnings Yield | 10.64% |
| Operating Earnings Yield | 2.87% |
| Normalized Earnings Yield | 10.64 |